Medikly, a New York-based software-as-a-service (SaaS) technology provider for pharmaceutical brands and agencies, has closed a $1.2 million Series A round of funding. The investment was led by Easton Capital Investment Group.

Kresimir Letinic of Easton Capital has joined Medikly’s board of directors, and James Golden, managing director, Life Science Analytics at Accenture, has become a board observer.